Divi’s Labs Shares Hit Fresh High, Rally 3.6%

Shares of Divi’s Laboratories hit a record high of Rs 7,208.50 on July 14, rising 3.64% despite weakness in the broader market.

The rally pushed the stock past its previous peak of Rs 6,963.70, hit back in mid May.

This wasn’t a one day move either. The stock has now risen for four straight sessions, adding around 6% in that stretch. That kind of steady climb, especially while the Sensex itself was down over half a percent on the day, tends to catch the eye of the market.

The rise also pushed Divi’s Labs closer to a big milestone. Its market capitalisation touched close to Rs 1.9 lakh crore during the day, putting the company within striking distance of the Rs 2 lakh crore mark.

Divi’s Lab is one of India’s larger pharmaceutical companies, working across active pharmaceutical ingredients and contract development and manufacturing for global clients. For the quarter ended March 2026, the company reported revenue of Rs 2,793 crore and a net profit of Rs 756 crore.

That’s a step up from the Rs 2,578 crore in revenue and Rs 598 crore in profit it posted the quarter before, in December 2025. Earnings per share for the March quarter stood at Rs 28.44, against Rs 22.56 the previous quarter.

The company’s operating margin for the March quarter came in at 39.28%, with net profit margin at 25.10%, both healthier than the December quarter’s 35.69% and 23.20% respectively.

By the end of the trading session, Divi’s Lab settled at Rs 7,185.20, up 3.64% for the day. The stock’s 52 week range now stands between Rs 5,637.50 and Rs 7,208.50, with today’s session marking a fresh high on that scale.

Tired of guessing stocks to trade in daily?

Tradz by EquityPandit empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more.

Download the Tradz by EquityPandit app today and take control of your investments!

The post Divi’s Labs Shares Hit Fresh High, Rally 3.6% appeared first on Equitypandit.